Key Highlights
- Dr. Armin Spura appointed as BioDuro-Sundia’s new CEO
- Brings over two decades of experience in life sciences and biotechnology
- Led Crown Bioscience as CEO for five years
- Previously held leadership roles at Thermo Fisher Scientific, WuXi NEXTCODE, CareDx, and Ion Torrent
- BioDuro-Sundia offers fully integrated CRDMO services from discovery to commercial manufacturing
Source: Business Wire
Notable Quotes
- “With our unique, fully integrated CRDMO platform — encompassing chemistry, biology, DMPK, drug substance, and drug product from discovery through to commercial manufacturing — I am confident we will empower more partners to bring better treatments to patients around the world faster.” — Dr. Armin Spura, CEO at BioDuro-Sundia
- “Dr. Spura’s extensive global experience and visionary leadership is instrumental in driving BioDuro-Sundia’s accelerated growth.” — Gary Chu, Chairman of the Executive Operation Committee at BioDuro-Sundia
SoHC's Take
The appointment of Dr. Armin Spura as CEO marks a strategic move for BioDuro-Sundia. With his proven track record in scaling companies and fostering innovation, particularly through his leadership at Crown Bioscience, BioDuro-Sundia is poised to accelerate its growth in the CRDMO sector. As the company strengthens its global presence, Spura’s leadership will likely play a pivotal role in expanding their integrated solutions and addressing the evolving needs of the life sciences industry. This leadership change could further enhance BioDuro-Sundia’s position as a leading CRDMO in the global market.
Heading
Key Highlights Shore Capital Partners launches Agentis Longevity to lead the longevity healthcare sector. Jimmy St Louis named CEO, bringing expertise from Regenerative Medicine ...
Key Highlights Nymbl Systems announces strategic partnership with Frontier Growth to accelerate growth and innovation. Frontier Growth brings 25+ years of growth equity expertise to ...
Key Highlights Launch of fingertip blood collection technology using BD’s MiniDraw™ and Babson’s BetterWay for U.S. health systems. Revolutionizes access with fewer ...
Key Highlights Anatomy Financial raises $19M in Series A funding, led by Canapi Ventures. Neil Underwood (Canapi) and Nicole Quinn ...
Key Highlights Wendy Barnes to assume role as GoodRx CEO on January 1, 2025. Brings 30+ years of leadership in pharmacy and healthcare benefit industries. Former CEO of RxBenefits and President of Express ...
Key Highlights Mike Butler, former Providence president, joins Linus Health's board of directors. Butler brings decades of healthcare leadership and ...
